{"url":"https://lda.senate.gov/api/v1/filings/5e08eee3-e8a3-450c-be58-c41ee536ef76/","filing_uuid":"5e08eee3-e8a3-450c-be58-c41ee536ef76","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2012,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/5e08eee3-e8a3-450c-be58-c41ee536ef76/print/","filing_document_content_type":"text/html","income":"37500.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Sara Zborovski","dt_posted":"2013-01-21T14:24:47.717000-05:00","termination_date":null,"registrant_country":"Canada","registrant_ppb_country":null,"registrant_address_1":"77 King Street West","registrant_address_2":"Suite 2010, P.O. Box 301","registrant_different_address":false,"registrant_city":"TORONTO","registrant_state":"ON","registrant_zip":null,"registrant":{"id":67876,"url":"https://lda.senate.gov/api/v1/registrants/67876/","house_registrant_id":35694,"name":"GILBERT'S LLP","description":null,"address_1":"THE FLATIRON BUILDING, FIRST FLOOR","address_2":"49 WELLINGTON STREET EAST","address_3":"TORONTO","address_4":"ON M5K1K2","city":"TORONTO","state":"ON","state_display":"ON","zip":"M5E 1-C9","country":"CA","country_display":"Canada","ppb_country":"CA","ppb_country_display":"Canada","contact_name":"TIM GILBERT","contact_telephone":"+1 416-703-1100","dt_updated":"2022-04-06T16:07:17.759172-04:00"},"client":{"id":163997,"url":"https://lda.senate.gov/api/v1/clients/163997/","client_id":36,"name":"MYLAN LABORATORIES INC","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Reform to legislation and regulations affecting pharmaceutical approvals and related patent issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48056,"prefix":"mr","prefix_display":"MR.","first_name":"TIM","nickname":null,"middle_name":null,"last_name":"GILBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}